These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23808015)

  • 1. [The metabolic syndrome and inflammation: actual issues of pathogenesis].
    Sveklina TS; Talantseva MS; Barsukov AV
    Klin Lab Diagn; 2013 Mar; (3):7-10. PubMed ID: 23808015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolically Healthy and Unhealthy Normal Weight and Obesity.
    Stefan N
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):487-493. PubMed ID: 32814419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome as a prohypertensive state.
    Mulé G; Cerasola G
    Am J Hypertens; 2008 Jan; 21(1):8. PubMed ID: 18268791
    [No Abstract]   [Full Text] [Related]  

  • 4. Controversies on obesity and CKD.
    Ito S
    Circ J; 2010 Mar; 74(3):428-9. PubMed ID: 20145337
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin.
    Furue M; Tsuji G; Chiba T; Kadono T
    Intern Med; 2017; 56(13):1613-1619. PubMed ID: 28674347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, inflammation, and kidney disease.
    Navarro-Díaz M; Serra A; López D; Granada M; Bayés B; Romero R
    Kidney Int Suppl; 2008 Dec; (111):S15-8. PubMed ID: 19034319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstructive sleep apnea, inflammation, and the metabolic syndrome.
    Calvin AD; Albuquerque FN; Lopez-Jimenez F; Somers VK
    Metab Syndr Relat Disord; 2009 Aug; 7(4):271-8. PubMed ID: 19344228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of increased cardiovascular disease in obesity and metabolic syndrome.
    Vazzana N; Santilli F; Sestili S; Cuccurullo C; Davi G
    Curr Med Chem; 2011; 18(34):5267-80. PubMed ID: 22087824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation, insulin resistance, and obesity.
    Ferroni P; Basili S; Falco A; Davì G
    Curr Atheroscler Rep; 2004 Nov; 6(6):424-31. PubMed ID: 15485587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study.
    Verhagen SN; Wassink AM; van der Graaf Y; Gorter PM; Visseren FL;
    Cardiovasc Diabetol; 2011 Nov; 10():100. PubMed ID: 22098712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift.
    Nolan CJ; Prentki M
    Diab Vasc Dis Res; 2019 Mar; 16(2):118-127. PubMed ID: 30770030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathobiology of metabolic syndrome X in obese and non-obese South Asian Indians: further discussion and some suggestions.
    Das UN
    Nutrition; 2003 Jun; 19(6):560-2. PubMed ID: 12781862
    [No Abstract]   [Full Text] [Related]  

  • 13. The cardiometabolic syndrome and sarcopenic obesity in older persons.
    Dominguez LJ; Barbagallo M
    J Cardiometab Syndr; 2007; 2(3):183-9. PubMed ID: 17786082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity-related cardiovascular risk in children and the role of lifestyle changes.
    Balagopal P
    J Cardiometab Syndr; 2006; 1(4):269-74; quiz 275-6. PubMed ID: 17679806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
    Pahwa R; Adams-Huet B; Jialal I
    J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and oxidative stress in obesity, metabolic syndrome, and diabetes.
    Galassetti P
    Exp Diabetes Res; 2012; 2012():943706. PubMed ID: 23319940
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenesis and pathophysiology of the cardiometabolic syndrome.
    Kirk EP; Klein S
    J Clin Hypertens (Greenwich); 2009 Dec; 11(12):761-5. PubMed ID: 20021538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperleptinemia, hyperinsulinemia and metabolic syndrome in cardiovascular risk: one for all and all for one].
    Botella Carretero JI
    Med Clin (Barc); 2004 Dec; 123(20):780-1. PubMed ID: 15607071
    [No Abstract]   [Full Text] [Related]  

  • 19. What is the metabolic syndrome? Prediabetes and cardiovascular risk.
    Borgman M; McErlean E
    J Cardiovasc Nurs; 2006; 21(4):285-90. PubMed ID: 16823282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uric acid as a risk factor for cardiovascular diseases].
    Cibičková Ľ; Karásek D
    Vnitr Lek; 2016; 62(11):919-923. PubMed ID: 28128580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.